Human promyelocytic leukemia HL-60 cells were induced to undergo granulocytic dierentiation by treatment with retinoic acid (RA, 10 mM, 1 ± 5 days). The steady-state level of nucleophosmin/B23 mRNA decreased during the RA-induced dierentiation. There was also decrease in the level of total cellular nucleophosmin/B23 protein during the RA-induced dierentiation. Stabilization and nuclear run-on assays indicate that the decrease in nucleophosmin/B23 mRNA in RA-treated HL-60 cells was transcriptionally regulated. Unlike c-myc mRNA, there was virtually no decline of nucleophosmin/B23 mRNA during the growth arrest by serum-starvation. The decrease in nucleophosmin/B23 mRNA expression in HL-60 cells subsequent to retinoic acid treatment can thus be attributed to cellular dierentiation rather than the growth arrest induced by RA. Nucleophosmin/B23 antisense oligomer treatment signi®cantly potentiated RA-induced cellular dierentiation. Results of this study suggest that nucleophosmin/ B23 is one of the key elements in the down-regulation of nucleolar function for cellular dierentiation.
Introduction
The human leukemic cell line HL-60 consists predominantly of rapidly dividing cells with promyelocytic characteristics (Collins et al., 1978) . Untreated cells spontaneously dierentiate (5 ± 10%) into forms that exhibit characteristics of more mature granulocytic cells, whereas the promyelocytes continue to proliferate at a constant rate (Collins et al., 1977) . Retinoic acid (RA) inhibits the proliferation of this cell line, and induces the cells to terminally dierentiate into mature functional myelocytes, metamyelocytes, and banded and segmented neutrophils (Breitman et al., 1980) . The identi®cation of genes and their products that are involved in response to growth stimuli is essential for understanding of the normal cell cycle process. During the past decade, numerous regulatory factors which control the balance between a cycling and quiescent state have been identi®ed. These factors include protooncogenes and negative and positive regulatory growth factors. Other proliferation-associated molecules are being studied to determine their potential role in cell cycle regulation (Fonagy et al., 1992; Chou and Yung, 1995) . Nucleophosmin/B23, also called protein B23, NO38, or numatrin (SchmidtZachmann et al., 1987; Yung et al., 1985) , is a major nucleolar phosphoprotein that displays a number of activities. These include a potential role as a positive regulator of cell proliferation. Nucleophosmin/B23 is signi®cantly more abundant in tumor and proliferating cells than normal resting cells (Feuerstein et al., 1988; Chan, 1989) . Steady-state levels of nucleophosmin/B23 have also been determined in normal and abnormal growth . Nucleophosmin/B23 mRNA is 50-and 5-fold higher in Noviko hepatoma and hypertrophic rat liver, respectively, when compared to normal rat liver . Nucleophosmin/B23 is localized in granular regions of the nucleolus (Spector et al., 1984; Peculis and Gall, 1992) , associated with preribosomal particles (Prestayko et al., 1974; Yung et al., 1985) and forms hexamers (Yung and Chan, 1987) which may be essential for the assembly of ribosomes. Our previous studies have shown that nucleophosmin/B23 translocates from nucleoli to nucleoplasm during the stationary phase of growth (Yung et al., 1990a) or during treatment with certain anti-tumor drugs, particularly the DNA intercalators (Yung et al., 1985; Yung et al., 1986 Yung et al., , 1990b Yung et al., , 1992 Wu et al., 1995) . Recent study by Valdez et al. (1994) demonstrates that nucleophosmin/B23 binds to amino acid sequence 24 ± 56 of protein p120, a cell cycle related protein. Studies of nucleophosmin/B23 suggest that nucleophosmin/B23 plays a role in the increased nucleolar activity that is necessary for cell proliferation.
The present study was undertaken to determine the changes of nucleophosmin/B23 during RA-induced cellular dierentiation of HL-60 cells. We have examined the steady-state level of nucleophosmin/ B23 mRNA during dierentiation by RA. Our ®ndings demonstrate that nucleophosmin/B23 is transcriptionally down-regulated by RA treatment. The decline of nucleophosmin/B23 mRNA is likely related to induced-dierentiation rather than the growth arrest during the treatment with RA. The potentiation of RA-induced dierentiation by nucleophosmin/B23 antisense oligomer strengthens the notion that nucleophosmin/B23 plays an important role in the down regulation of nucleolar function for cellular dierentiation.
Results
Eect of RA on nucleophosmin/B23 mRNA A single mRNA band hybridizing with the nucleophosmin/B23 cDNA probe was observed in the Northern blot of rapidly proliferating promyelocytic leukemic HL-60 cells (Figure 1 ). The steady-state level of nucleophosmin/B23 mRNA, as determined by the levels of radioactivity of the hybridizing bands, decreased during the RA-induced granulocytic differentiation (Figure 1 ). After 1 day of 10 mM RA treatment, nucleophosmin/B23 expression decreased to less than 20% and continued to be that low at times measured up to 5 days.
Eect of RA on nucleophosmin/B23 protein level
Total cellular protein samples (containing equal amounts of protein) from control untreated HL-60 cells and the HL-60 cells treated with 10 mM RA for various times (1 ± 5 days) were separated by 10% SDS ± PAGE and subsequently analysed by Western blot immunoassay. The lower and upper panels of Figure 2a shows the Commassie blue-stained SDS ± PAGE and chromogenic diagrams of Western blot analysis, respectively. The immunoband of nucleophosmin/B23 was present in all the control untreated and RA-treated cells. The results showed that there was a decrease in the level of total cellular nucleophosmin/ B23 protein during the RA-induced dierentiation (Figure 2a ). To obtain a better quantitation, serial dilutions of total cellular proteins from the control and RA-treated (1 ± 5 days) cells were prepared and were analysed for the nucleophosmin/B23 immunoband by Western blotting. The results after densitometry analysis (Figure 2b ) indicated that there was also down-regulation of nucleophosmin/B23 in total cellular protein level of nucleophosmin/B23 during RA-induced dierentiation.
Nucleophosmin/B23 mRNA expression is transcriptionally down-regulated during dierentiation by RA To compare the stability of nucleophosmin/B23 transcripts in uninduced versus RA-induced (1 or 3 days) HL-60 cells, the half-lives of nucleophosmin/B23 mRNA transcripts were analysed by incubating the cells with actinomycin D (5 mg/ml) for up to 12 h (Figure 3a) . The dierentiated HL-60 cells had been treated with 10 mM RA for 1 or 3 days before the addition of actinomycin D. The densitometry analysis showed that there were even slight increases in the halflives in dierentiated cells (Figure 3b) . Thus, the marked decrease in nucleophosmin/B23 mRNA levels during RA-induced dierentiation was really not due to post-transcriptional regulation.
To determine whether nucleophosmin/B23 mRNA transcripts are decreased in HL-60 cells during RAinduced dierentiation because of the alterations of transcriptional activity in nuclei, nuclear run-on assays were used. The transcriptional activity of the nucleophosmin/B23, c-myc, and 18S genes after RAinduced dierentiation is shown in Figure 4 . In control experiments, the plasmid without an insert exhibited little nonspeci®c hybridization to RNA probes (data not shown), whereas hybridization to plasmids containing various genes were seen (Figure 4a ). There were signi®cant decreases in the transcription of nucleophosmin/B23 and c-myc genes relative to 18S during the 12 and 24 h treatment with RA ( Figure 4a ). By densitometric estimation, the transcription rates of nucleophosmin/B23 and c-myc decreased to approximately 30% of the untreated after treatment with RA for 24 h (Figure 4b ). The results thus demonstrated that there were decreases in both of the transcriptional rates of the nucleophosmin/B23 and c-myc genes during RA-induced dierentiation of HL-60 cells. In fact, this situation seems to be quite similar to the data with c-myc in DMSO-induced HL-60 dierentiation, which has been described before (Grosso and Pitot, 1985) .
Little change in nucleophosmin/B23 mRNA expression after growth arrest without dierentiation HL-60 cells do arrest growth when deprivated of serum from the growth medium. Similar to the RA-induced growth inhibition, HL-60 cells were arrested at G 1 /S phase by serum starvation (Figure 5a ). In growtharrested cells, the abundance of nucleophosmin/B23 mRNA did not change while those of c-myc was reduced markedly (Figure 5b) . In contrast to c-myc mRNA expression presently shown in HL-60 cells ( Figure 5 ) or in previous study in F9 cells (Dean et al., 1986) , the decline of the expression of nucleophosmin/ B23 mRNA is rather related to induced-dierentiation than the growth arrest during the treatment with RA.
Potentiation of RA-induced dierentiation by nucleophosmin/B23 antisense oligomer
The use of antisense oligonucleotides have been proposed as a method for elucidating the function of speci®c genes. Northern blot analysis ( Figure 6 ) showed there were signi®cant decreases in mRNA Viability of the cells were over 90% under these RA-treatment conditions (data not shown). Cells were then harvested and the total RNA was prepared. Northern blot analysis was performed with 3 mg of RNA for each sample. The same ®lter was hybridized with 32 P-labeled 18S cDNA probe that was used as a control for the amount of RNA loaded levels of nucleophosmin/B23 in the cells treated with nucleophosmin/B23 antisense oligomer as compared to the control untreated cells. Nucleophosmin/B23 antisense oligomer treatment signi®cantly potentiated RAinduced (10 mM, 1 ± 3 days) cellular dierentiation (Table 1, Figure 7 ). About 12 ± 66% of control untransfected or the nucleophosmin/B23 sense oligomer-transfected cells were dierentiated after 1 ± 3 days of RA treatment (Table 1) . Between 35 ± 82% of cells transfected with nucleophosmin/B23 antisense oligomer, on the other hand, became mature myelocytes or granulocytes after 1 ± 3 days of 10 mM RA treatment (Table 1, Figure 7 ). Nucleophosmin/B23 sense or antisense oligomer alone without addition of RA caused virtually no eect on dierentiation of HL-60 cells. The impact of the nucleophosmin/B23 antisense manipulations on dierentiation was further strengthened by functional assessment of the ability to reduce nitrobluetetrazolium. Higher percentages of nucleophosmin/B23 antisense oligomer-transfected cells at- Eect of RA on total nucleophosmin/B23 protein level. HL-60 cells were treated with 10 mM RA for various times (1 ± 5 days). Cells were then harvested, washed and the lysates were centrifuged at 12 000 g for 30 min at 48C. (a) 30 mg of total cellular proteins were separated by 10% SDS ± PAGE stained with Coomassie Blue (lower panels) or blotted onto PVDF papers (upper panels). The blotted papers were incubated with monoclonal anti-nucleophosmin/B23 antibody for 2 h at room temperature. Immunoreactivity was determined using the chromogenic development. (b) Two-to fourfold serial dilutions of total cellular proteins were separated by 10% SDS ± PAGE and blotted onto PVDF papers for nucleophosmin/B23 immunodetection. The nucleophosmin/B23 protein band intensities were determined by densitometry scanning. One hundred percent represents the nucleophosmin/B23 protein levels of uninduced cells without dilution tained ability to reduce nitrobluetetrazolium during RA treatment, as compared to the sense oligomertransfected or untransfected HL-60 cells (Table 2 ). There were decreases of expression of dierentiation marker CD15 during RA-induced dierentiation (Figure 8 ), as previously reported in RA-induced F9 cells (Cho et al., 1996) . The decrease of the expression of CD15 was enhanced by nucleophosmin/B23 antisense oligomer treatment in RA-induced differentiation.
Discussion
Nucleophosmin/B23 is known to be enriched in proliferating cells and thought to be involved in ribosome assembly and transport due to its localization to the granular region of the nucleolus (Spector et al., 1984) . Nucleophosmin/B23 has been ascribed a number of diverse properties, including a potential role in proliferation due to its rapid increase in synthesis during mitogenic stimulation (Feuerstein and Mond 1987b) ; a role as a cytoplasmic/nuclear shuttle protein (Borer et al., 1989) ; has DNA binding activity (Dumbar et al., 1989) ; relieves transcription repression by YY1 (Inouye and Seto, 1994) ; binds the HIV Type 1 Rev protein (Fankhauser et al., 1991) , the human Tcell leukemia virus-1-Rex protein (Adachi et al., 1993) , and another cell cycle-regulated nucleolar oncoprotein p120 (Valdez et al., 1994) ; is a substrate of protein kinase C (Beckmann et al., 1992) , mitotic cdc2 kinase (Peter et al., 1990) , and casein kinase II (Pfa and Anderer, 1988) ; can be ADP-ribosylated (Leitinger and Wesierska-Gadek, 1993) . Nucleophosmin/B23 is of potential interest because it is involved in at least three distinct forms of hematologic malignancy. The N-terminal region of nucleophosmin/B23 is fused to ALK tyrosine kinase in anaplastic lymphoma with t(2;5) (Morris, 1994) , retinoic acid receptor a in acute promyelocytic leukemia with t(5;17) (Redner et al., 1996) , and a novel gene called MLF1 in myelodyplastic syndrome with t(3;5) (Yoneda et al., 1996) . In light of many potential roles of nucleophosmin/ B23, it is conceivable that it plays important role in the regulation of cell growth. In the present studies, HL-60 mRNA when compared with control HL-60 cells. The nucleophosmin/B23 protein levels, on the other hand, persists after 24 h of negligible transcript (Figures 1  and 2 ). It has been previously reported that nucleophosmin/B23 has a half-life of 18 ± 20 h (Chan, 1992) . Our results indicate that nucleophosmin/B23's half-life is also long during RA-induced cellular dierentiation. The stabilities of the nucleophosmin/ B23 transcripts of uninduced and RA-induced cells are similar. In contrast, measurements of the relative rates of synthesis of nucleophosmin/B23 gene indicate that, subsequent to dierentiation, a decrease in nucleophosmin/B23-speci®c transcription occurs. These studies demonstrate that transcriptional regulation is a major component of the control of the nucleophosmin/ B23 gene, but we cannot exclude the involvement of additional mechanisms in the control of nucleophosmin/B23 mRNA levels. Furthermore, the decreased proliferation under serum starvation, in the absence of dierentiation while resulting in reduced expression of P-labeled 18S cDNA probe that was used as a control for the amount of RNA loaded. *HL-60 cells were exposed to serum-free medium for 48 h and were subsequently released in serum-containing medium for 24 h
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6 h 12 h 6 h 12 h 6 h 12 h Control Control RA AS AS+RA Figure 6 Eect of nucleophosmin/B23 antisense oligonucleotide on nucleophosmin/B23 mRNA level. Ten micromolar nucleophosmin/B23 antisense oligomer (AS) was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 antisense oligomer. The cells were then incubated with 10 mM RA for 6 ± 12 h. Cells were then harvested and the total RNA was prepared. Northern blot analysis was performed with 3 mg of RNA for each sample. The same ®lter was hybridized with 32 P-labeled 18S cDNA probe that was used as a control for the amount of RNA loaded Table 1 Nucleophosmin/B23 antisense oligomer enhanced RA-induced granulocytic dierentiation. 10 mM nucleophosmin/B23 sense or antisense oligomer was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 sense or antisense oligomer. The cells were incubated with 10 mM RA for 1 ± 3 days. 5 mM nucleophosmin/B23 sense or antisense oligomer was added on the second and third days of RA treatments. Morphological assessment of the induced cells was performed using the Wright-Giemsa staining method as described in Materials and methods c-myc has little eect on nucleophosmin/B23's expression ( Figure 5 ). Nucleophosmin/B23's expression remains elevated in growth-inhibited undierentiated cells. Our results thus indicate that changes in nucleophosmin/B23's expression in HL-60 cells subsequent to RA treatment can be attributed primarily to the cell dierentiation process. Lack of¯uctuation at the levels of nucleophosmin/B23 mRNA during growth arrest and growth stimulation also suggests that nucleophosmin/B23 is not stringently regulated in undierentiated HL-60 cells ( Figure 5 ). On the other hand, dierentiation of HL-60 cells leads to a decrease in the steady-state level of nucleophosmin/B23 mRNA, suggesting that normal regulation of nucleophosmin/ B23 gene expression is restored during the differentiation process. Previous ®ndings indicate that the steady-state level of nucleophosmin/B23 mRNA is signi®cantly higher in abnormal growth as compared to normal growth. The other recent important ®ndings about nucleophosmin/B23 related to our present studies were that of Patterson et al. (1995) who reported a decrease in nucleophosmin/B23 labeling in apoptotic cells and that of Feuerstein and Mond (1987a) , who reported a 68% inhibition of synthesis of nucleophosmin/B23 as a result of anti-m-induced growth arrest. Our present results indicate that the down-regulation of nucleophosmin/B23 plays an important role in the induction of dierentiation. In Ten micromolar nucleophosmin/B23 sense or antisense oligomer was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 sense or antisense oligomer. The cells were incubated with 10 mM RA for 1 ± 3 days. Five micromolar nucleophosmin/B23 sense or antisense oligonucleotide was further added on the second and third day of RA treatments. Morphological assessment of the induced cells was performed using the Wright-Giemsa staining method as described in Materials and methods. Bar=20 mm Table 2 Assessment of the potentiating eect of nucleophosmin/B23 antisense manipulations on dierentiation as measured by the ability to reduce nitrobluetetrazolium. 10 mM nucleophosmin/B23 sense or antisense oligomer was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 sense or antisense oligomer. The cells were incubated with 10 mM RA for 1 ± 2 days. 5 mM nucleophosmin/B23 sense or antisense oligomer was added on the second day of RA treatments. Dierentiation was monitored by the ability to reduce nitrobluetetrazolium as described in Materials and methods Table is representative of the results obtained in several (at least three) replications of the experiment. Viability of the cells was over 90% under these conditions further support of this speculation, it is shown that transfection with nucleophosmin/B23 antisense oligomer signi®cantly enhances RA-induced cellular differentiation of HL-60 cells. These transfection experiments suggest a functional role for nucleophosmin/B23 gene in growth/dierentiation control, and its down-regulation could be associated with mortalization of tumor cells. The tumor cells treated with nucleophosmin/B23 antisense oligomers contain markedly reduced levels of nucleophosmin/B23 mRNA and are more susceptible and prone to be induced to dierentiate. The potentiation ability of nucleophosmin/B23 antisense in RA-induced cellular differentiation is particularly interesting and may lead to the use of antisense construct in cancer treatment. Whether the decrease of nucleophosmin/B23 mRNA as a result of antisense treatment would render tumor cells more susceptible to chemotherapeutics is under current investigation. Our preliminary results show that treatment of HL-60 cells with nucleophosmin/B23 antisense could also result in potentiation of TPAinduced monocytic dierentiation.
Mature
The present results implicate the down-regulation of nucleophosmin/B23 in the control of cellular differentiation. Important future studies will thus be to elucidate the mechanism of enhancement of induction of cellular dierentiation under the antisense oligomer treatment and eventually to understand how nucleophosmin/B23 plays a role in the regulation of nucleolar function for cellular growth and differentiation.
Materials and methods
Cell culture and antibody HL-60 promyelocytic leukemic cells were grown in suspension in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 0.5% antibiotics and 2.0 g/L sodium bicarbonate in a 5% CO 2 humidi®ed incubator at 378C. The monoclonal antibody (MAb) to nucleophosmin/B23 (37/5.1) was kindly provided by Dr PK Chan, Department of Pharmacology, Baylor College of Medicine, Houston, Texas. Characterization of nucleophosmin/B23 MAb has been reported previously (Spector et al., 1984) .
Oligonucleotides
The phosphorothioate analogs of deoxyoligonucleotides corresponding to nucleotides 72*18 of the nucleophosmin/B23 cDNA (Li et al., 1989) were synthesized in both of the sense (5'-CGA TGG AAG ATT CGA TGG AC-3') and antisense (5'-GTC CAT CGA ATC TTC CAT CG-3') orientations (ASIA Company Ltd, Oregon-Wilsonville). These synthetic deoxyoligonucleotides comprised the 5'-region of the nucleophosmin/B23 cDNA including the translation initiation codon.
Induction of dierentiation
In the induction of dierentiation, HL-60 cells (2610 5 cells/ml) were incubated with 10 mM RA (all-trans). Dierentiation along the granulocytic pathway was monitored by characteristic changes in cellular and nuclear morphology (Wright-Giemsa staining), and the ability to reduce nitrobluetetrazolium. The percentages of CD-15-positive cells and¯uorescence intensity were evaluated by FACScan (FACScan, Beckton-Dickinson) using speci®c anti-CD15 FITC-conjugated monoclonal antibodies (Sigma).
Wright-Giemsa stain
Morphological assessment of the induced cells was performed using the Wright-Giemsa staining method. Cells (4610 4 ) were prepared on slides by Cytospin (Shandon Southern, UK) and stained with WrightGiemsa. The morphology of cells were examined under a light microscope (6400). The criteria for judging the morphology were according to those previously described (Tsiftsoglou and Robinson, 1985) . The percentages of myelocytes, metamyelocytes, banded and segmented neutrophils were assessed as mature granulocytic dierentiated cells. Two hundred-cell counts each from triplicate samples of an experiment were performed. Figure 8 Nucleophosmin/B23 antisense oligomer potentiates the decrease of the CD15 expression during RA-induced differentiation. 10 mM nucleophosmin/B23 sense or antisense oligomer was added to the HL-60 cell cultures. Control cultures were left untreated. After 1 day of oligomer treatment, the culture medium was replaced with fresh medium containing 10 mM nucleophosmin/B23 sense or antisense oligomer. The cells were incubated with 10 mM RA for 1 ± 2 days. Five micromolar nucleophosmin/ B23 sense or antisense oligonucleotide was further added on the second day of RA treatments. After the cells were harvested, expressions of the CD15 was evaluated by¯uorescent cytometry using speci®c anti-CD15 FITC-conjugated monoclonal antibodies Electrophoresis Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) was carried out according to the protocol of Laemmli, 1970) .
Western blotting
Separated proteins in SDS ± PAGE were electrotransferred to Hybond-PVDF membrane (Amersham). The PVDF membrane was then soaked in a blocking solution [5% (w/v) non-fat milk in TBST buer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 0.1% (v/v) Tween-20)] for 1 h at room temperature. The soaked PVDF membrane was then incubated with MAb against nucleophosmin/B23 (diluted 1 : 2000 in 3% (w/v) non-fat milk in TBST) for 1 h at room temperature, washed with TBST buer three times for 15 min each and incubated at room temperature for 1 h in horse-radish peroxidase conjugated goat anti-mouse IgG antibody (diluted 1 : 2000 in TBST buer). The membrane was washed three times with TBST for 15 min each. Immunobands were identi®ed by chromogenic development.
RNA analysis
Total RNA was prepared from HL-60 cells by ULTRA-SPEC TM RNA Isolation System (Biotecx). For Northern blot analysis, aliquots of 3 mg of RNA were separated by 1.2% formaldehyde agarose gel electrophoresis, transferred to nitrocellulose membranes (Nytran, Schleicher & Schuell) by downward alkaline capillary method (Chomczynski, 1992) and ®xed to the membrane by drying at 808C for 30 min. The nucleophosmin/B23 cDNA (Li et al., 1989) labeled with [a-32 P]dCTP using a random primed kit (Promega) was employed as a probe for detection of homologous mRNA. Prehybridization was carried overnight at 428C in a solution containing 50% formamide, Denhardt's solution, 56SSC (16SSC=0.15 M NaCl, 0.015 M sodium citrate), 0.1% SDS, and 250 mg/ml denatured salmon sperm DNA. Radiolabeled probe at a speci®c activity of 1 ± 2610 8 cpm/mg was hybridized with total RNA in the same solution for 24 h at 428C. Washings of the membranes for the probes were: twice in 26SSC and 0.1% SDS at room temperature for 5 min; twice in 26SSC and 0.5% SDS at 428C for 10 min, and once in 0.16SSC and 0.5% SDS at room temperature for 30 min. The radioactive nucleophosmin/B23 homologous mRNA was determined by autoradiography with phosphoimager or with intensifying screen at 7708C.
Nuclear run-on transcription assays
A total of 2.5610 7 HL-60 cells were washed twice in cold phosphate-buered saline, suspended in 500 ml of lysis buer [10 mM Tris (pH 7.4), 20 mM NaCl, 1.5 mM MgCl 2 , 0.1% NP40], centrifuged at 500 g for 5 min, washed twice with lysis buer, suspended in 100 ml of storage buer [50 mM Tris (pH 8.3). 40% glycerol, 5 mM MgCl 2 , 0.1 mM EDTA], and stored at 7808C. A total of 10 mg of linearized denatured plasmid DNAs containing nucleophosmin/B23, c-myc, and 18S cDNA fragments per slot were transferred to nitrocellulose membrane by using a slot-blot apparatus, and prehybridized overnight in hybridization solution [50% Formamid (Merck), 56SSC, 10% SDS, 16 Denhardt's solution, and 250 mg/ml of Salmon sperm DNA]. The nuclei were incubated with 100 ml reaction buer [10 mM Tris (pH 8.0), 5 mM DTT, 5 mM MgCl 2 , 300 mM KCl, and 0.5 mM ATP, CTP, GTP] and 100 mCi of [a-32 P]UTP (Amersham, 3000 Ci/mmole), and incubated for 30 min at 308C. The newly synthesized RNA was extracted with ULTRASPEC TM RNA Isolation System and hybridized with 3610 6 CPM/ml at 428C for approximately 72 h. Filters were then washed three times in 26SSC at 508C. Each nascent transcript was determined by scanning autoradiographs and was corrected by the reference with each 18S transcript.
Transfection with antisense nucleophosmin/B23 oligonucleotides HL-60 cells were seeded at a density of 3610 5 per well in 1.0 ml OPTI-MEM I reduced serum medium (Gibco). Ten micromolar oligonucleotide and 6 mg lipofectin reagents in OPTI-MEM I reduced serum medium were mixed gently. The mixture was incubated for 45 min at room temperature, added to the HL-60 cells and was incubated for 24 h at 378C in the CO 2 incubator. The culture medium was then replaced with fresh RPMI 1640 medium containing 10 mM nucleophosmin/B23 sense or antisense oligonucleotide. The cells were incubated with 10 mM RA for 1 ± 3 days. Five micromolar nucleophosmin/B23 sense or antisense oligonucleotide was further added on the second and third day of RA treatments.
